make or break time, page-17

I think all holders are ready for the worst.

I's say the results might be hard to digest, with not all the end points being met. It seems unlikely that the primary endpoint will be met IMO, if it is though it would cause a huge gap in the opening.

I say this based on Gary's interpretation from the conference call of how just meeting some of the ends could still be hugely positive for the company, this sort of gave the impression that it could still potentially lead to a label change with the EMA for specific sub groups. Also from comments re what they've already learned, the complexity of the trial, and how it's been broken down into specific sub groups- leads me to believe certain sub groups would have responded far better than others...